Autolus Therapeutics Reports Second Quarter 2022 Financial Results and Operational Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. FRBT
4. SPY
5. KRG
6. EROC
7. FFAI
8. SKA-B
9. SEER
10. ALAR

Go back to Autolus Therapeutics Reports Second Quarter 2022 Financial Results and Operational Progress

Autolus Therapeutics (AUTL) Misses Q2 EPS by 4c

August 4, 2022 7:05 AM EDT

Autolus Therapeutics (NASDAQ: AUTL) reported Q2 EPS of ($0.46), $0.04 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

... More